There are tests now that claim to measure how old you really are. Not the number on your birth certificate, but your biological age, the idea being that two people born on the same day can be aging at different speeds, and that a blood or saliva sample can tell them apart. It starts with a discovery from fifteen years ago, that chemical marks on your DNA shift as you get older. Since then, the clocks built on it have moved fast, from reading your age, to forecasting how long you have left, to scoring each organ, to scoring individual cell types from a single vial of blood. So what does one of these numbers actually measure, how good have they become, and would one handed to your doctor change anything about what happens to you?

0:00 – Can You Really Measure Your Age?
1:04 – The Cheek Swab That Started It
4:00 – Reading Death, Not Birthdays
5:45 – The Hidden Flaw
7:51 – Your Organs Age Differently
8:36 – 11 Ages, One Blood Draw
10:06 – 40 Clocks, One Vial
11:36 – The Missing Proof
14:15 – The Verdict

*Citations can be found on my website

For decades the reassuring story about tattoos was that the ink stays put: a permanent mark, sealed in the skin, chemically done with your body. It isn't. Pigment migrates out of the skin and lodges in your lymph nodes, carrying the carcinogens it came with, and it stays there for the rest of your life. That's not in dispute. What is in dispute is whether any of it actually causes cancer, and in 2024 and 2025 several teams finally ran the studies. They came back contradicting each other, one country finds tattoos raise melanoma risk, another finds the opposite, and the strongest study designs find nothing at all. So what does the evidence actually show, where's the real risk, and who's regulating what goes into the bottle?

0:28 The stained node no one could explain

2:01 What's actually in tattoo ink

3:28 The body's immune response to ink

7:23 Ink and vaccine response

8:42 Where the ink migrates to

12:30 Tattoos and cancer risk

14:44 Conflicting skin cancer data

16:03 A confounding factor in the data

17:27 The risk of laser removal

19:32 How tattoo ink is regulated

23:35 Practical takeaways

For most of a decade, vitamin D came with a warning: take it on its own, and the calcium it raises ends up in your arteries instead of your bones. The fix, supposedly, is vitamin K2. The claim is unusually specific for supplement advice, specific enough to put to randomized, placebo-controlled trials with arterial calcium scored on CT before and after. The trials came back. They don't agree with each other. So what does the evidence actually show, and did a 2026 trial change the answer?

0:00 – The trio everyone's told to take together

1:09 – The magnesium story

2:47 – Why K2 is different

3:45 – Putting it to the test

4:15 – What the trials found

5:55 – What you should actually do

6:40 – K2: cutting through the hype

7:06 – When it makes sense, when it doesn't

For most of the last century, apigenin was a footnote — a yellow pigment in chamomile and parsley, studied mostly by people cataloguing the antioxidants in plants. In the last few years it has become one of the most-recommended compounds on the internet: the third ingredient in the famous sleep stack, a fixture in longevity protocols built around NAD+, and an addition to formulas aimed at cellular aging itself. But how does the evidence hold up?

0:00 - Introduction

0:45 - Why apigenin is everywhere right now

2:30 - How apigenin works

4:30 - Human anxiety trials

6:00 - Second discovery

8:00 - What the marketing gets wrong

10:45 - Where the evidence actually stands

12:20 - Should you take it?

For decades, magnesium sat in the supplement aisle as a mineral for muscle cramps, sleep, and general nutrition. Around 2010, that changed. A branded form called magnesium L-threonate launched on the back of a 2010 MIT rodent paper, and a new category was born — magnesium for the brain. Fifteen years later, that category has expanded to include other brand-targeted forms, premium price points, and confident claims about cognition, memory, and synaptic density. In this investigation, we review the science underneath those claims.

IN THIS INVESTIGATION

• What two papers from 1984 actually said about magnesium and the brain
• Why magnesium concentrates differently in brain fluid than in blood, and what that implies for supplementation
• The 2010 MIT paper that launched the brand-targeted magnesium category, and the question it didn't answer
• What you find when you trace the authorship of the rodent studies that "independently confirmed" the original
• The magnesium acetyl taurate line and what a 2026 head-to-head comparison reveals about form-specific brain delivery
• Every human trial on magnesium L-threonate, who funded each one, and the structural feature they all share
• The 2024 paper that directly measured magnesium inside living human brains for the first time in twenty-five years
• What the ordinary forms — citrate, chloride, oxide — have actually demonstrated in independent human trials
• Why a failed 2007 traumatic brain injury trial matters for everything that followed
• The single piece of evidence the brand-targeted magnesium story has never produced
• What to do if you take magnesium for cognitive reasons

Subscribe for more investigations.

For thirty years, the supplement aisle has sold fish oil as one of the simplest decisions you can make for your brain. In 2026, two research teams on opposite sides of the world published papers that complicate that story, and the literature behind them has been building for almost twenty years.

IN THIS INVESTIGATION

• What a 2026 ADNI cohort study of 800+ older adults actually found
• Why faster cognitive decline in fish oil users showed up on every measure
• What the brain imaging revealed when classic Alzheimer's pathology came back negative
• The 2026 Cell Reports mechanism work in repetitive brain injury
• Why EPA and DHA do different things inside the brain, and why most trials ignored the difference
• Twenty years of cognitive trials nobody connected, including a 2006 trial whose biomarkers, re-analyzed in 2021, told a different story
• What the 2026 authors themselves said about how to read their own findings
• Dose, baseline status, oil quality, and physiological context; the conditions the supplement aisle has never asked about
• What twenty years of brain literature actually supports if you take fish oil today

Subscribe for more investigations.

PREFACE: This is an explanation of the debate the guidelines have stimulated. It references the data used to rationalize the guidelines and the data used to oppose them. There is nothing here that was not cited by the new or old guidelines. For a full review, please see my website.

The 2025–2030 Dietary Guidelines introduced changes that have caused confusion, disagreement, and strong reactions across nutrition and public health. In this episode of Daily Value, we walk through what actually changed, what didn’t, and why, explaining the evidence standards, policy constraints, and scientific disagreements that shaped the guidelines. The goal isn’t to tell you what to eat, but to help you understand how national nutrition policy is made, and why this cycle looks different from those before it.

00:00 Introduction to the Dietary Guidelines Controversy

01:16 Understanding the Dietary Guidelines

02:48 The Shift in Scientific Foundations

07:23 The Diet-Heart Hypothesis Debate

11:36 Reevaluating Full-Fat Dairy

15:15 The Ongoing Debate and Its Implications

19:28 Conclusion and Further Reading

Omega-3 supplements are at the center of a controversy regarding their oxidation levels and potential harm. This presentation addresses the gap between claims of harm and the available human data, explaining how oxidation is measured and interpreted.

00:00 Introduction to Omega-3 Supplements

00:49 Understanding Oxidation in Fish Oil

01:10 Measuring Oxidation: Peroxide, Anisidine, and Totox Values

01:50 The Flavoring Problem in Oxidation Testing

02:46 Market Surveys and Oxidation Failures

04:08 Do Oxidation Standards Correlate with Human Harm?

04:30 Clinical Trials on Oxidized Fish Oil

06:54 Regulatory Perspectives on Oxidation and Safety

07:57 Summary and Takeaways

09:08 Conclusion and References